Live Breaking News & Updates on Leptomeningeal Metastases|Page 1

Stay updated with breaking news from Leptomeningeal metastases. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Plus Therapeutics Provides Highlights Regarding Leptomeningeal Metastases Acquisition and Topline Clinical Trial Data on the FORESEE Trial

Plus Therapeutics Provides Highlights Regarding Leptomeningeal Metastases Acquisition and Topline Clinical Trial Data on the FORESEE Trial
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

United States , San Antonio , Priyau Kumthekar , March Hedrick , Charlesy Huang , Therapeutics Inc , Northwestern University , Cancer Prevention Research Institute Of Texas , Feinberg School Of Medicine , National Cancer Institute , Us National Institutes Of Health , Edge Media Service Transcript , Associate Professor , Feinberg School , Plus Therapeutics President , Chief Executive , Edge Media Service , Leptomeningeal Metastases , Cancer Prevention , Research Institute , Non Small Cell Lung Cancer , Clinical Evaluation , Plus Therapeutic , Plus Therapeutics , Capital Markets ,

Plus Therapeutics to Host Investor Call to Discuss

Plus Therapeutics to Host Investor Call to Discuss
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United States , San Antonio , Charlesy Huang , March Hedrick , Us National Institutes Of Health , National Cancer Institute , Cancer Prevention Research Institute Of Texas , Therapeutics Inc , Chief Executive Officer , Non Small Cell Lung Cancer , Leptomeningeal Metastases , Clinical Evaluation , Cancer Prevention , Research Institute , Plus Therapeutic , Plus Therapeutics , Capital Markets ,

Plus Therapeutics To Host Investor Call To Discuss Leptomeningeal Cancer Related Acquisition And Topline Clinical Trial Data From The FORESEE Trial

Plus Therapeutics To Host Investor Call To Discuss Leptomeningeal Cancer Related Acquisition And Topline Clinical Trial Data From The FORESEE Trial
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United States , San Antonio , March Hedrick , Charlesy Huang , Us National Institutes Of Health , Therapeutics Inc , Cancer Prevention Research Institute Of Texas , Nasdaq Company , National Cancer Institute , Chief Executive Officer , Non Small Cell Lung Cancer , Leptomeningeal Metastases , Clinical Evaluation , Cancer Prevention , Research Institute , Plus Therapeutic , Plus Therapeutics , Capital Markets ,

Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial

Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

San Antonio , United States , Charlesy Huang , March Hedrick , Cancer Prevention Research Institute Of Texas , National Cancer Institute , Therapeutics Inc , Us National Institutes Of Health , Globenewswire Inc , Chief Executive Officer , Non Small Cell , Leptomeningeal Metastases , Clinical Evaluation , Cancer Institute , Research Institute , Plus Therapeutic , Capital Markets ,

Plus Therapeutics Announces Validation & Clinical Implementation of CSF-01 Leptomeningeal Cancer Cell Diagnostic

Plus’ CSF-01 cancer cell enumeration test is a sensitive and specific diagnostic test for the presence of adenocarcinoma and melanoma cancer cells in the leptomeninges CSF-01 testing is used as an exploratory endpoint in the ReSPECT-LM trials Controlled clinical trial data evaluating the utility of CSF-01 in clinical decision-making is anticipated to be released in Q2/Q3 2024 AUSTIN, Texas, March 25, 2024 (GLOBE NEWSWIRE) Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stag ....

United States , San Francisco , San Antonio , Corey Davis , March Hedrick , Priya Kumthekar , Us National Institutes Of Health , Northwestern University , Clinical Laboratory Improvement Amendments , Research Institute Of Texas , National Cancer Institute , Therapeutics Inc , Feinberg School Of Medicine , Cancer Prevention Research Institute Of Texas , Associate Professor , Feinberg School , Cancer Prevention , Research Institute , Leptomeningeal Metastases , Plus Therapeutic , Plus Therapeutics , Clinical Trials , Leptomeningeal Metastases , The Company , Central Nervous System , Pharmaceutical Company ,